AmerisourceBergen Aktie - Fundamentalanalyse - Dividendenrendite KGV

AmerisourceBergen (ISIN: US03073E1055, WKN: 766149) Kursdatum: 18.05.2018 Kurs: 84,770 USD
Beschreibung Daten
Symbol ABC
Marktkapitalisierung 18.785.202.176,00 USD
Land Vereinigte Staaten von Amerika
Indizes S&P 500
Sektor Pharma
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2009-06-16 - 2.0000/1.0000 | 2005-12-29 - 2.0000/1.0000 | 1999-03-25 - 2.0000/1.0000 |
Internet www.amerisourcebergen.com
Letztes Bilanz Update 28.11.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 18.05.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
18,10 12,49 2,17% 1,03 5,85 51,69 0,12 9,10

Firmenbeschreibung

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company\'s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.amerisourcebergen.com